ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.

Hiu-Fung Yuen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.